LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H

As of December 31, 2025, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H carries a market capitalization of 5.58B, placing it among publicly traded companies globally. Its enterprise value stands at 4.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H's next confirmed earnings release is scheduled for March 26, 2027.

As of December 31, 2025, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has 346.75M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H maintains a current ratio of 23.54, meaning it holds 23.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H's stock has declined approximately 27.81% over the past 52 weeks. The 50-day moving average sits at 12.40, while the 200-day moving average is 13.08.

As of December 31, 2025, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H holds 1.31B in cash and equivalents against 860,269.91 in total debt, resulting in a net debt position of -1.29B. Total book value stands at 2.27B, with working capital of 1.52B providing operational flexibility.